2019
DOI: 10.1080/01480545.2019.1607371
|View full text |Cite
|
Sign up to set email alerts
|

Safety assessment of MEFAS: an innovative hybrid salt of mefloquine and artesunate for malaria treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Cure disease Artemether Lumefantrine Antimalaria [ 120,121] Dihydroartemisinin Piperaquine Antimalaria [ 121] Pyropheophorbide-iron Anticancer [121] Artesunate Amodiaquine Anti-malaria; Anti-EBOV [ 122] Mefloquine Anti-malaria [ 123] Lamivudine Anti-HBV [ 112] Thymoquinone hybrids Anti-CMV [66] 8 years of using artemether-amphetamine combination therapy for simple P. falciparum malaria in Bagamoyo district, Tanzania, also showed promising results with a high and sustained cure rate. [26] Vathsala et al found ART associated with curcumin might prevent recurrence of P. falciparum malaria.…”
Section: Common Partnersmentioning
confidence: 99%
“…Cure disease Artemether Lumefantrine Antimalaria [ 120,121] Dihydroartemisinin Piperaquine Antimalaria [ 121] Pyropheophorbide-iron Anticancer [121] Artesunate Amodiaquine Anti-malaria; Anti-EBOV [ 122] Mefloquine Anti-malaria [ 123] Lamivudine Anti-HBV [ 112] Thymoquinone hybrids Anti-CMV [66] 8 years of using artemether-amphetamine combination therapy for simple P. falciparum malaria in Bagamoyo district, Tanzania, also showed promising results with a high and sustained cure rate. [26] Vathsala et al found ART associated with curcumin might prevent recurrence of P. falciparum malaria.…”
Section: Common Partnersmentioning
confidence: 99%